RVLP Annual CFO
-$37.81 M
+$16.92 M+30.92%
31 December 2022
Summary:
As of February 5, 2025, RVLP annual cash flow from operations is -$37.81 million, with the most recent change of +$16.92 million (+30.92%) on December 31, 2022. During the last 3 years, it has fallen by -$71.38 million (-212.64%).RVLP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVLP Quarterly CFO
-$12.06 M
-$6.24 M-107.32%
30 June 2023
Summary:
As of February 5, 2025, RVLP quarterly cash flow from operations is -$12.06 million, with the most recent change of -$6.24 million (-107.32%) on June 30, 2023. Over the past year, it has dropped by -$14.06 million (-704.31%).RVLP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVLP TTM CFO
-$44.41 M
-$14.06 M-46.32%
30 June 2023
Summary:
As of February 5, 2025, RVLP TTM cash flow from operations is -$44.41 million, with the most recent change of -$14.06 million (-46.32%) on June 30, 2023. Over the past year, it has increased by +$7.19 million (+13.94%).RVLP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVLP Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.9% | -704.3% | +13.9% |
| 3 y3 years | -212.6% | -173.7% | -182.2% |
| 5 y5 years | -165.4% | -68.6% | -232.3% |
RVLP Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -165.4% | -132.6% | -170.2% |
RVL Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$12.06 M(+107.3%) | -$44.41 M(+46.3%) |
| Mar 2023 | - | -$5.82 M(-64.6%) | -$30.35 M(-19.7%) |
| Dec 2022 | -$37.81 M(-30.9%) | -$16.43 M(+62.8%) | -$37.81 M(-17.4%) |
| Sept 2022 | - | -$10.10 M(-605.9%) | -$45.77 M(-11.3%) |
| June 2022 | - | $2.00 M(-115.0%) | -$51.60 M(-8.7%) |
| Mar 2022 | - | -$13.28 M(-45.6%) | -$56.52 M(+3.3%) |
| Dec 2021 | -$54.73 M(-411.2%) | -$24.39 M(+53.1%) | -$54.73 M(+41.8%) |
| Sept 2021 | - | -$15.93 M(+445.1%) | -$38.59 M(+194.1%) |
| June 2021 | - | -$2.92 M(-74.6%) | -$13.12 M(-312.7%) |
| Mar 2021 | - | -$11.49 M(+39.2%) | $6.17 M(-64.9%) |
| Dec 2020 | $17.59 M | -$8.25 M(-186.5%) | $17.59 M(-33.7%) |
| Sept 2020 | - | $9.54 M(-41.7%) | $26.52 M(-50.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | $16.36 M(<-9900.0%) | $54.03 M(+36.3%) |
| Mar 2020 | - | -$64.00 K(-109.5%) | $39.63 M(+18.1%) |
| Dec 2019 | $33.57 M(-10.6%) | $675.00 K(-98.2%) | $33.57 M(-47.0%) |
| Sept 2019 | - | $37.05 M(+1782.7%) | $63.28 M(+89.1%) |
| June 2019 | - | $1.97 M(-132.1%) | $33.45 M(+37.5%) |
| Mar 2019 | - | -$6.13 M(-120.2%) | $24.33 M(-35.2%) |
| Dec 2018 | $37.56 M(-35.1%) | $30.38 M(+320.4%) | $37.56 M(+423.5%) |
| Sept 2018 | - | $7.23 M(-201.0%) | $7.17 M(<-9900.0%) |
| June 2018 | - | -$7.16 M(-200.8%) | -$53.90 K(-100.8%) |
| Mar 2018 | - | $7.10 M | $7.10 M |
| Dec 2017 | $57.84 M(-229.1%) | - | - |
| Dec 2016 | -$44.79 M | - | - |
FAQ
- What is RVL Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals annual CFO year-on-year change?
- What is RVL Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals quarterly CFO year-on-year change?
- What is RVL Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals TTM CFO year-on-year change?
What is RVL Pharmaceuticals annual cash flow from operations?
The current annual CFO of RVLP is -$37.81 M
What is the all time high annual CFO for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high annual cash flow from operations is $57.84 M
What is RVL Pharmaceuticals annual CFO year-on-year change?
Over the past year, RVLP annual cash flow from operations has changed by +$16.92 M (+30.92%)
What is RVL Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of RVLP is -$12.06 M
What is the all time high quarterly CFO for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high quarterly cash flow from operations is $37.05 M
What is RVL Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, RVLP quarterly cash flow from operations has changed by -$14.06 M (-704.31%)
What is RVL Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of RVLP is -$44.41 M
What is the all time high TTM CFO for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high TTM cash flow from operations is $63.28 M
What is RVL Pharmaceuticals TTM CFO year-on-year change?
Over the past year, RVLP TTM cash flow from operations has changed by +$7.19 M (+13.94%)